
AdaptHealth Corp (AHCO) Stock Forecast & Price Target
AdaptHealth Corp (AHCO) Analyst Ratings
Bulls say
AdaptHealth Corp demonstrated robust performance in its Sleep segment, achieving a 3.4% year-over-year revenue growth and maintaining a consistent new start rate of over 120,000 for three consecutive quarters. The company has also shown strong financial flexibility by reducing its term loan balance by approximately $50 million, leading to an improved net leverage ratio of 2.79x, moving closer to its 2.5x target while also reporting a stellar free cash flow of $235.8 million, up 64.7% year-over-year. With plans to invest in technology enhancements, expanded capabilities, and strategic acquisitions, AdaptHealth is well-positioned for continued growth and increased market share in the healthcare-at-home solutions industry.
Bears say
AdaptHealth Corp is anticipated to experience a year-over-year revenue decline of 3% to 4% in the first quarter, largely due to weaknesses in its Diabetes segment and a challenging purchase/rental mix impacting overall performance. The company has revised its revenue estimate down from $3.309 billion to $3.230 billion, reflecting a modest decline of 0.9% and projecting adjusted EBITDA of $672 million, a decrease from $691 million, indicating difficulties in achieving organic growth and operational leverage. Additionally, management's expectation that not all payment term benefits from 2024 will recur in 2025 further contributes to a cautious outlook, compounded by the forecasted downside scenario suggesting significant integration challenges and lower-than-expected EBITDA margins.
This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.
AdaptHealth Corp (AHCO) Analyst Forecast & Price Prediction
Start investing in AdaptHealth Corp (AHCO)
Order type
Buy in
Order amount
Est. shares
0 shares